On September 7, 2021 Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, reported that members of the company’s management will present and conduct one-on-one meetings at the following virtual investor conferences (Press release, Abeona Therapeutics, SEP 7, 2021, View Source [SID1234587316]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual BioPharma Virtual Conference on September 8-10, 2021 (one-on-one meetings only).

H.C. Wainwright 23rd Annual Global Investment Conference. The pre-recorded presentation will be available beginning September 13, 2021 at 7:00 a.m. ET throughout the conference ending September 15, 2021.

SVB Leerink CybeRx Series Neuromuscular, Rare Diseases & Genetic Medicines on September 22-23, 2021 (one-on-one meetings only).

Cantor Fitzgerald Virtual Global Healthcare Conference on Thursday, September 30, 2021 at 3:20 p.m. ET.
The company presentations will be available on the investor section of the Abeona Therapeutics website at www.abeonatherapeutics.com. The webcast replays will be available within 24 hours of the live presentation and will be accessible for 90 days.